Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.08 HKD
963.97 M HKD
29.49 B HKD
5.04 B
About ALIBABA HEALTH INFORMATION TECH LTD
Sector
Industry
CEO
Di Fan Shen
Headquarters
Hong Kong
FIGI
BBG000BDZJK6
Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to offer medical and healthcare services. Its activities include self-operated healthcare product sales, e-commerce platform services, tracking services, and innovative healthcare related services and others. The company was founded on March 11, 1998 and is headquartered in Hong Kong.
Alibaba Healthcare Units Prepares for Next Battle in HealthcareAffected heavily by recent technological advancements, the sector may soon attract Chinese regulators' attention.
Background
2021 turned out to become a positive year for China's healthcare industry, where the gigantic demand stems from the aging population, growing individual wealth, and – more
Opportunity in Chaos !Read latest article here
Some followers are worried about the future of Alibaba and its subsidiaries business with the recent investigation by the Chinese government. Unfortunately, I do not have any insider information to pass on so we have to make do with what we have.
1. Is this drop in share
Own this great company at a discount Let's wait for the pullback to happen, find a nice bullish candle signal before initiating a long position.
Note that breakout does not means it must rides it way up. It could goes up a little before tumbling down to the support at 17.42. This support is crucial for the bullish continuation patter
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 241 is 4.57 HKD — it has increased by 1.33% in the past 24 hours. Watch ALIBABA HEALTH INFORMATION TECH LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ALIBABA HEALTH INFORMATION TECH LTD stocks are traded under the ticker 241.
241 stock has risen by 4.82% compared to the previous week, the month change is a −15.37% fall, over the last year ALIBABA HEALTH INFORMATION TECH LTD has showed a 73.76% increase.
We've gathered analysts' opinions on ALIBABA HEALTH INFORMATION TECH LTD future price: according to them, 241 price has a max estimate of 7.02 HKD and a min estimate of 3.40 HKD. Watch 241 chart and read a more detailed ALIBABA HEALTH INFORMATION TECH LTD stock forecast: see what analysts think of ALIBABA HEALTH INFORMATION TECH LTD and suggest that you do with its stocks.
241 stock is 3.13% volatile and has beta coefficient of 2.29. Track ALIBABA HEALTH INFORMATION TECH LTD stock price on the chart and check out the list of the most volatile stocks — is ALIBABA HEALTH INFORMATION TECH LTD there?
Today ALIBABA HEALTH INFORMATION TECH LTD has the market capitalization of 73.49 B, it has increased by 8.51% over the last week.
Yes, you can track ALIBABA HEALTH INFORMATION TECH LTD financials in yearly and quarterly reports right on TradingView.
ALIBABA HEALTH INFORMATION TECH LTD is going to release the next earnings report on May 27, 2025. Keep track of upcoming events with our Earnings Calendar.
241 earnings for the last half-year are 0.067 HKD per share, whereas the estimation was 0.066 HKD, resulting in a 1.22% surprise. The estimated earnings for the next half-year are 0.075 HKD per share. See more details about ALIBABA HEALTH INFORMATION TECH LTD earnings.
ALIBABA HEALTH INFORMATION TECH LTD revenue for the last half-year amounts to 15.81 B HKD, despite the estimated figure of 16.53 B HKD. In the next half-year revenue is expected to reach 16.93 B HKD.
241 net income for the last half-year is 833.40 M HKD, while the previous report showed 474.54 M HKD of net income which accounts for 75.62% change. Track more ALIBABA HEALTH INFORMATION TECH LTD financial stats to get the full picture.
No, 241 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 18, 2025, the company has 1.44 K employees. See our rating of the largest employees — is ALIBABA HEALTH INFORMATION TECH LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALIBABA HEALTH INFORMATION TECH LTD EBITDA is 1.32 B HKD, and current EBITDA margin is 2.55%. See more stats in ALIBABA HEALTH INFORMATION TECH LTD financial statements.
Like other stocks, 241 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALIBABA HEALTH INFORMATION TECH LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALIBABA HEALTH INFORMATION TECH LTD technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALIBABA HEALTH INFORMATION TECH LTD stock shows the neutral signal. See more of ALIBABA HEALTH INFORMATION TECH LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.